Electrocardiographic Screening for Prolonged QT Interval to Reduce Sudden Cardiac Death in Psychiatric Patients: A Cost-Effectiveness Analysis

PLoS One. 2015 Jun 12;10(6):e0127213. doi: 10.1371/journal.pone.0127213. eCollection 2015.

Abstract

Importance: Sudden cardiac death is a leading cause of mortality in psychiatric patients. Long QT (LQT) is common in this population and predisposes to Torsades-de-Pointes (TdP) and subsequent mortality.

Objective: To estimate the cost-effectiveness of electrocardiographic screening to detect LQT in psychiatric inpatients.

Design, setting, and participants: We built a decision analytic model based on a decision tree to evaluate the cost-effectiveness and utility of LQT screening from a health care perspective. LQT proportion parameters were derived from an in-hospital cross-sectional study. We performed experts' elicitation to estimate the risk of TdP, given extent of QT prolongation. A TdP reduction of 65% after LQT detection was based on positive drug dechallenge rate and through adequate treatment and electrolyte adjustments. The base-case model uncertainty was assessed with one-way and probabilistic sensitivity analyses. Finally, the TdP related mortality and TdP avoidance parameters were varied in a two-way sensitivity analysis to assess their effect on the Incremental Cost-Effectiveness Ratio (ICER).

Main outcomes and measures: Costs, Quality Ajusted Life Year (QALY), ICER, and probability of cost effectiveness thresholds ($ 10,000, $25,000, and $50,000 per QALY).

Results: In the base-case scenario, the numbers of patients needed to screen were 1128 and 2817 to avoid one TdP and one death, respectively. The ICER of systematic ECG screening was $8644 (95%CI, 3144-82 498) per QALY. The probability of cost-effectiveness was 96% at a willingness-to-pay of $50,000 for one QALY. In sensitivity analyses, results were sensitive to the case-fatality of TdP episodes and to the TdP reduction following the diagnosis of LQT.

Conclusion and relevance: In psychiatric hospitals, performing systematic ECG screening at admission help reduce the number of sudden cardiac deaths in a cost-effective fashion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Arrhythmias, Cardiac
  • Brugada Syndrome
  • Cardiac Conduction System Disease
  • Cost-Benefit Analysis*
  • Death, Sudden, Cardiac / epidemiology*
  • Death, Sudden, Cardiac / etiology*
  • Electrocardiography* / economics
  • Female
  • Heart Conduction System / abnormalities
  • Humans
  • Male
  • Mass Screening
  • Mental Disorders / complications*
  • Mental Disorders / epidemiology*
  • Middle Aged
  • Prevalence
  • Probability
  • Quality-Adjusted Life Years
  • Risk Factors
  • Torsades de Pointes / complications
  • Torsades de Pointes / diagnosis
  • Torsades de Pointes / epidemiology
  • Young Adult

Grants and funding

The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The Department of Anesthesiology, Intensive Care, Clinical Pharmacology and Toxicology (University Hospitals of Geneva), and the Medical Directorate of the University Hospitals of Geneva supported the economic assessment for safety guidance in psychiatry. BG’s research on cardiovascular prevention is supported by a grant from the Swiss National Science Foundation (SNSF SPUM33C30-140336, Inflammation and acute coronary syndromes (ACS) – Novel strategies for prevention and clinical management) and by a grant from the Geneva University Hospital (CRG 71-225) for the development of research projects.